IvyRock Asset Management »

Beam Therapeutics shares owned by IvyRock Asset Management

Quarter-by-quarter ownership of Beam Therapeutics (BEAM) shares owned by IvyRock Asset Management from 13F filings

Historical chart of IvyRock Asset Management investment in Beam Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Beam Therapeutics held by IvyRock Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Beam Therapeutics by IvyRock Asset Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $209k 8.6k 24.27

More positions owned by IvyRock Asset Management

Pdd Holdings Sponsored Ads (PDD)
Legend Biotech Corp Sponsored Ads (LEGN)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Alibaba Group Hldg Sponsored Ads (BABA)
Ishares Ethereum Tr SHS (ETHA)
Zai Lab Adr (ZLAB)
Spdr Gold Tr Gold Shs (GLD)
Bloom Energy Corp Com Cl A (BE)
Direxion Shs Etf Tr Daily S&p Biotch (LABU)
So Young International Sponsored Ads (SY)
Microsoft Corporation (MSFT)
Arrowhead Pharmaceuticals (ARWR)
Advanced Micro Devices (AMD)
Cisco Systems (CSCO)
Intellia Therapeutics (NTLA)

View all positions for IvyRock Asset Management

Top funds holding Beam Therapeutics

FMR
ARK Investment Management
Farallon Capital Management
Vanguard Group
BlackRock
Sumitomo Mitsui Trust Holdings
Nikko Asset Management Americas
Arch Venture Corp
State Street Corporation
Bellevue Group
Kynam Capital Management
Geode Capital Management
MWG Management
Dimensional Fund Advisors
Ubs Global Asset Management Americas

View all funds holding Beam Therapeutics